SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-016061
Filing Date
2018-11-16
Accepted
2018-11-16 16:18:29
Documents
1
Period of Report
2018-11-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3980
  Complete submission text file 0001213900-18-016061.txt   5636
Mailing Address 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703
Business Address 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703 919-941-5206
Icagen, Inc. (Issuer) CIK: 0001518520 (see all company filings)

IRS No.: 200982060 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O CALDERA PHARMACEUTICALS, INC ONE KENDALL SQUARE, BUILDING 200 SUITE 2 CAMBRIDGE MA 02139
Business Address
Cunningham, Richard Anthony (Reporting) CIK: 0001624783 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54748 | Film No.: 181190028